BioLineRx (BLRX) Tops Q3 EPS by 8c
BioLineRx (NASDAQ: BLRX) reported Q3 EPS of $0.00, $0.08 better than the analyst estimate of ($0.08). Revenue for the quarter came in at $430 thousand versus the consensus estimate of $4.62 million.
For earnings history and earnings-related data on BioLineRx (BLRX) click here.
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share